Investment set to Spur Oral Medicines Growth
Andreas Ulrich
Company site at Wolfratshaus
Company site at Wolfratshaus
Wolfsberg premises
Wolfsberg premises

News

Investment set to Spur Oral Medicines Growth

06 Oct, 2023

Published over 2 years ago. See the latest and most current information on News.

CDMO and full service provider Hermes Pharma is investing a further €25 million in its manufacturing capabilities, arming the company with new equipment, increased production and storage capacity, as well as greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. The investment forms part of the company’s strategy to drive future growth, while helping new and existing customers to realise theirs.

The pharmaceutical industry has long seen traditional tablets and capsules as the ‘gold standard’ of oral dosage forms. However, studies suggest that around 50% of people struggle to take them. Consequently, demand for easy-to-swallow oral dosage forms, such as orally disintegrating granules (ODGs), chewable tablets, lozenges, instant drinks and effervescents, is soaring, with healthcare companies seeking to add them to their portfolios.

Having specialised in user-friendly dosage forms for more than twenty years, the new investment in its specialist manufacturing plants, is focused on powering the company’s growth while unlocking greater scale, flexibility and cost-efficiency for customers. This will include new large-volume coating equipment to support growing need for advanced taste-masking; new filling and packaging lines for ODGs and instant drinks; expanded Good Manufacturing Practice (GMP) manufacturing and storage space; and optimised flow of inventory/goods on the shop floor.

“As pharmaceutical companies race to find ways to better serve patients and differentiate themselves in a competitive market, we’re seeing unprecedented demand for more patient-centric products,” said Dr Andreas Ulrich, COO of HERMES PHARMA . “Our latest investment will help us meet that demand, delivering ever greater service for our customers, while also helping us serve new customers across different market segments. We look forward to getting new and improved user-friendly dosage forms to patients quickly and more efficiently than ever before.”

More information online

Latest News

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
WATCH: How to perform effective, compliant CEMS monitoring in India
Explore more Arrow
Pollution Solutions Online
AtkinsRéalis appoints Ian Dyck as global water market lead to drive growth in water infrastructure sector
Explore more Arrow
Petro Online
Safer, faster on-site density checks for aviation fuel
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow